Improving the Intercellular Uptake and Osteogenic Potency of Calcium Phosphate via Nanocomplexation with the RALA Peptide
Authors:
- Michelle O’dohertyMOMichelle O’doherty
- Eoghan J. MulhollandEMEoghan J. Mulholland
- Philip ChambersPCPhilip Chambers
- Sreekanth PentlavalliSPSreekanth Pentlavalli
- Monika ZiminskaMZMonika Ziminska
- Marine J. ChalanquiMCMarine J. Chalanqui
- Hannah M. PaulyHPHannah M. Pauly
- Binulal N. SathyBSBinulal N. Sathy
- Tammy H. DonahueTDTammy H. Donahue
- Daniel J. KellyDKDaniel J. Kelly
- Nicholas DunneNicholas Dunne
- Helen O. McCarthyHelen O. McCarthy
Open Access
- 7 December 2020
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 10 (12) , 2442
Abstract
Calcium phosphate-base materials (e.g., alpha tri-calcium phosphate (α–TCP)) have been shown to promote osteogenic differentiation of stem/progenitor cells, enhance osteoblast osteogenic activity and mediate in vivo bone tissue formation. However, variable particle size and hydrophilicity of the calcium phosphate result in an extremely low bioavailability. Therefore, an effective delivery system is required that can encapsulate the calcium phosphate, improve cellular entry and, consequently, elicit a potent osteogenic response in osteoblasts. In this study, collagenous matrix deposition and extracellular matrix mineralization of osteoblast lineage cells were assessed to investigate osteogenesis following intracellular delivery of α-TCP nanoparticles. The nanoparticles were formed via condensation with a novel, cationic 30 mer amphipathic peptide (RALA). Nanoparticles prepared at a mass ratio of 5:1 demonstrated an average particle size of 43 nm with a zeta potential of +26 mV. The average particle size and zeta potential remained stable for up to 28 days at room temperature and across a range of temperatures (4–37 °C). Cell viability decreased 24 h post-transfection following RALA/α-TCP nanoparticle treatment; however, recovery ensued by Day 7. Immunocytochemistry staining for Type I collagen up to Day 21 post-transfection with RALA/α-TCP nanoparticles (NPs) in MG-63 cells exhibited a significant enhancement in collagen expression and deposition compared to an untreated control. Furthermore, in porcine mesenchymal stem cells (pMSCs), there was enhanced mineralization compared to α–TCP alone. Taken together these data demonstrate that internalization of RALA/α-TCP NPs elicits a potent osteogenic response in both MG-63 and pMSCs.Keywords
Funding Information
- Medical Research Council – Concept in Confidence Programme (MC_PC_12021)
- Engineering Science Research Council – MeDe Innovation Programme (EP/K029592/1)
- Department for the Economy (Northern Ireland) US-Ireland Research Partnership (USI-044)
This publication has 50 references indexed in Scilit:
- Interactions Between Inorganic and Organic Phases in Bone Tissue as a Source of Inspiration for Design of Novel NanocompositesTissue Engineering Part B: Reviews, 2014
- The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formationProceedings of the National Academy of Sciences, 2012
- Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A reviewActa Biomaterialia, 2012
- Nano-hydroxyapatite particles induce apoptosis on MC3T3-E1 cells and tissue cells in SD ratsNanoscale, 2012
- The osteogenic differentiation of human osteoprogenitor cells on Anodic-Plasma-Chemical treated Ti6Al7NbBiomaterials, 2011
- Cytotoxicity of Calcium Phosphate Crystals and Human-Derived Nanoparticles: An Overlooked LinkCirculation Research, 2010
- NEMO Nuances NF-κBCirculation Research, 2010
- Normal Bone Anatomy and PhysiologyClinical Journal of the American Society of Nephrology, 2008
- Molecular simulation of protein adsorption and desorption on hydroxyapatite surfacesBiomaterials, 2008
- Total Attenuated Reflection Infrared Analysis of Silicon-Stabilized Tri-Calcium PhosphateThe Journal of Physical Chemistry B, 2005